TU1.R3: Biopharmaceutical Reaction Engineering I
Tue, 18 Feb, 10:45 - 11:45 CT (UTC -6)
Location: Room 3
Session Type: Oral
Track: Biopharmaceutical Reaction Engineering – All Modalities
Click the to view the manuscript on IEEE Xplore Open Preview
Tue, 18 Feb, 10:45 - 11:05 CT (UTC -6)

TU1.R3.1: Development of continuous hydrogenation for pharmaceutical intermediate from Laboratory to Pilot plant
Onkar Manjrekar, Greg Storer, Brian Kotecki, Jie Chen, Moiz Diwan, AbbVie, United States
Tue, 18 Feb, 11:05 - 11:25 CT (UTC -6)

TU1.R3.2: DEVELOPMENT OF PHARMACEUTICALLY-RELEVANT PHOSPHOLIGANDS FROM LAB TO PLANT VIA MULTI-STAGE FLOW CHEMISTRY
Eric Sacia, Anna Bay, Shashank Shekhar, Kaid Harper, Justin Simanis, Simona Slater, Onkar Manjrekar, Christopher Vitale, AbbVie, United States
Tue, 18 Feb, 11:25 - 11:45 CT (UTC -6)

TU1.R3.3: DEVELOPMENT AND DEMONSTRATION OF AN ULTRA-HIGH TEMPERATURE CONTINUOUS RACEMIZATION PROCESS FOR RECYCLE OF UNDESIRED ATROPISOMER WASTE STREAM
Kiersten Campbell, Eric Fang, David Ford, Kevin Nagy, Jillian Sheeran, Snapdragon Chemistry, Inc., A Cambrex Company, United States
©2024 North American Symposium For Chemical Reaction Engineering.
Last updated Last updated 14 November 2024.
Contact: info@2025.nascre.org
Host: https://cmsworldwide.com/